Using the classic procedure of blood monocyte derived DC culture (in the presence of IL-4 and GM-CSF), the ex vivo yield of DCs was found to be significantly reduced in patients with cancer, particularly in those with breast cancer. The gene discussed is CSF2; the disease is cancer.